While Affymetrix Enjoys Lead in DNA Mircroarray Sector, Competitors Vie For This Top Position
A recent survey revealed that more than eighty percent of researchers used commercial DNA microarrays, and among these users, seventy five percent used Affymetrix [NASDAQ: AFFX] arrays. The DNA microarray industry market is expected to exceed $930 million within five years, and is a fast growing market; more than sixty percent of scientists plan to increase their throughput over the next year. While Affymetrix is the current industry leader, Agilent Technologies [NYSE: A] and Applied Biosystems [NYSE: ABI] are making progress into this growing market, both in the areas of microarray scanners and data analysis software. Scientists use arrays for research areas including drug discovery and SNP detection and diagnosis. However, market research conducted by Bioinformatics, LLC, discovered that an emerging application for arrays would be in clinical applications. These survey results and the expected growth of the DNA microarray market make for prime conditions for increased and aggressive competition for Affymetrix.